| Sultopride | |
|---|---|
| Salts [] | |
|---|---|
| Sultopride hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 354.5 g/mol [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H26N2O4S [1] |
| IUPAC name | N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide [1] |
| SMILES | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)CC)OC [1] |
| InChI | InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20) [1] |
| InChIKey | UNRHXEPDKXPRTM-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3 – 5 hours |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - oral: 665 mg/kg - intraperitoneal: 300 mg/kg |
Sultopride
Sultopride (also known as Sultopridum, Sultoprida, N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-, N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide, N-((1-ethylpyrrolidin-2-yl)methyl)-5-ethylsulfonyl-2-methoxy-benzamide, RefChem:890031, N05AL02, N-(Ethyl-1-pyrrolidinyl-2-methyl)methoxy-2-ethylsulfonyl-5-benzamide or 258-641-9) is a
Chemistry
Salts []
Sultopride is typically found in the form of its hydrochloride salt.
Stereochemistry []
Sultopride is a racemic mixture of the enantiomers
| Stereoisomers |
|---|
Legal status
- Brazil: Sultopride is a C1 substance.[3]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5357, Sultopride. Accessed October 2, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5357
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sultopride. UNII: AA0G3TW31W. Global Substance Registration System. Accessed October 2, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AA0G3TW31W
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed October 2, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Anodyne